ADD3 Deletion in Glioblastoma Predicts Disease Status and Survival

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

(2021) David N Louis et al.   NEURO-ONCOLOGY

Loss of cytoskeleton protein ADD3 promotes tumor growth and angiogenesis in glioblastoma multiforme

(2020) Karrie Mei-Yee Kiang et al.   CANCER LETTERS

Adducins inhibit lung cancer cell migration through mechanisms involving regulation of cell-matrix adhesion and cadherin-11 expression

(2018) Susana Lechuga et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics

(2017) Martin J. van den Bent et al.   NEURO-ONCOLOGY

Endoplasmic reticulum chaperone prolyl 4-hydroxylase, beta polypeptide (P4HB) promotes malignant phenotypes in glioma via MAPK signaling

(2017) Stella Sun et al.   Oncotarget

Loss of Heterozygosity at the Calcium Regulation Gene Locus on Chromosome 10q in Human Pancreatic Cancer

(2015) Jin Long et al.   Asian Pacific Journal of Cancer Prevention

Association of loss of heterozygosity with shorter survival in primary glioblastoma patients

(2013) Dorota Jesionek-Kupnicka et al.   POLISH JOURNAL OF PATHOLOGY

Loss of heterozygosity on chromosome 10q in glioblastomas, and its association with other genetic alterations and survival in Indian patients

(2011) Vaishali Suri et al.   NEUROLOGY INDIA

Inhibition of Mxi1 suppresses HIF-2α-dependent renal cancer tumorigenesis

(2010) Chun Chui Tsao et al.   CANCER BIOLOGY & THERAPY

Adducins Regulate Remodeling of Apical Junctions in Human Epithelial Cells

(2010) Nayden G. Naydenov et al.   MOLECULAR BIOLOGY OF THE CELL

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

(2008) Roger McLendon et al.   NATURE